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Abstract
With rising costs and increasing complexities, many hospitals seek to better
understand the intricate details of their operations. Increasingly, these organizations have
a strong desire to accurately predict the resources required to effectively treat their patient
load. This research investigates patient length-of-stay in a hospital neurological unit
using an empirical modeling approach. Factors significantly affecting patient length of
stay were identified and used to construct a regression model. The predictive model
provides hospital decision makers with a compact tool to input what-if scenarios and
predict future patient treatment lengths, thus, allowing the hospital to properly allocate
resources.
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ANALYSIS OF PATIENT INFORMATION:
AN EMPIRICAL MODELING APPROACH

I. Introduction
1.1 Overview
Currently, there is a growing need and interest to improve the quality and
efficiency of health care, which emphasizes the necessity of good indicators to determine
this. Furthermore, hospitals and other health care facilities are experiencing difficulties
providing reliable care while maintaining sizable profits. As a result, many are looking at
innovative ways to better utilize the often limited resources they have. Several have
determined the best way to accomplish this is to better understand and ultimately exercise
better control over their operations. Because it is often related to total costs, managing
patient length-of-stay (LOS) has become the main focus in health care settings and many
hospitals have turned to LOS prediction models to improve their resource utilization
[Blais 2003, Omachonu 2004].
Hospitals have a strong desire to be able to accurately predict LOS and, more
specifically, costs by using the often limited information from incoming patients. LOS is
becoming an increasingly important and primary performance indicator for hospitals and
other health care facilities and has often been used as an indicator of inpatient care
efficiency [Blais 2003]. Due to its clear meaning as one of the main sources of hospital
costs and because it can also be used as an indicator of quality patient care, it is often
viewed as a measure of effective treatment and as a means for managing cost. Because
of this, hospital administrators generally focus on LOS as an indicator of the quality of
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care and as an important variable in determining budgets based on access (i.e.,
admissions to the unit per year). As a result, many hospitals have dedicated countless
efforts and resources to better understand what ultimately determines LOS [Omachonu
2004].
Ideally, these facilities would wish to rely on predetermined expected LOS
values, which are calculated based on statistical patient data from the previous fiscal year
[Centers for Medicare and Medicaid Services 2002]. However, this approach does not
consider how these expected values may be impacted by certain patient characteristics or
other factors. In most cases, a younger, healthier patient with little or no medical history
is going to have a shorter LOS than a frailer, elderly one who has had prior related
diagnoses. However, the current system makes no adjustment in these instances.
Consequently, these expected LOS values tend to have excessive variability which
obviously makes them highly unreliable.
An alternative is to model the current hospital operation, or system, to more
accurately predict an incoming patient’s LOS. These prediction models generally use
historical patient data to determine the predominant factors and indicators that drive LOS
and costs. While patient characteristics are the obvious predictors to use, clinical aspects
such as physician experience and hospital policies have also been used.
Multiple regression analysis is typically used to build these models. After
validation testing, these models can be analyzed using simulation software, which will
derive statistical operating characteristics, such as mean LOS and patient load, of the
entire hospital system as a whole. Ultimately, hospital administrators will have a model
that not only characterizes their entire operation, but also has the capability to analyze
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various what-if scenarios affecting resource utilization.

1.2 Problem Objective
Using neurological patient data provided by a local hospital, a prediction model
will be created to determine patient LOS and an indirect associated cost of treatment.
Using this model, a hospital could match their performance compared to the government
standard and consider dropping more costly treatments in exchange for more profitable
ones. They could also allocate and schedule resources, such as beds and staff,
accordingly. Other items the model may be used to determine:
•

Are there certain patient profiles that are prone to have longer/shorter stays
compared to the expected LOS?

•

What, if any, insurance providers encourage a shorter stay compared to other
providers?

•

Are there certain profiles the hospital should target to reduce LOS and/or increase
profit?

1.3 Method of Approach
1.3.1 Problem Background
Good Samaritan Hospital of Dayton, OH, is one of the leading health care
facilities in southwestern Ohio. It is currently performing a major renovation to its
facilities with its neurology department being expanded as a result of this. With this
upgrade, the hospital will become a leading certified stroke care unit in the area and is
expected to see a dramatic increase in not only stroke patients, but neurosurgical and
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neuromedical cases as well. Also, another neurosurgeon is expected to be hired in the
near future, further increasing the influx of patients. Because of these changes, the
hospital feels it needs a better understanding of its operations. They also desire to know
the consequences of varying resource allocations, such as beds and staffing.

1.3.2 Overview of Neurology and Neurological Disorders
Neurology is the branch of medicine that deals with the central nervous system
and its disorders. Neurological disorders are those affecting the central nervous system
(brain, brainstem, cerebellum), the peripheral nervous system (peripheral nerves - cranial
nerves), or the autonomic nervous system (parts of which are contained in both of the
former). While stroke is the most common neurological ailment, other disorders include
migraine headaches, epileptic seizures, and cerebral palsy [National Institutes of Health
2006].
Stroke is defined as rapidly developed clinical signs of focal (or global)
disturbance of cerebral function, lasting more than 24 hours or leading to death. Though
its cause has yet to be determined, it is usually due to a blockage of an artery in the brain,
called a cerebral infraction. In minor instances, stroke results from a cerebral
hemorrhage, or rupture of a blood vessel in the brain. More information on neurology
and all neurological disorders can be found at the website of the National Institute of
Neurological Disorders and Stroke: http://www.ninds.nih.gov [National Institutes of
Health 2006].
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1.3.3 Patient Classification (Diagnostic Related Groups)
Hospitals classify medical patients into clinically cohesive groups, called
Diagnostic Related Groups (DRGs), which typically consume the same amount and type
of hospital resources. The DRG system was implemented in 1983 when Congress
mandated a national hospital prospective payment system (PPS) for all Medicare patients.
The PPS utilizes DRGs to determine hospital reimbursement. The Centers for Medicare
and Medicaid Services (CMS) administers the PPS and issues all rules and changes with
regard to DRGs. Although the DRG system was originally intended exclusively for
Medicare patients, many hospitals now use it as a means to charge all their patients.
However, the actual payment of non-Medicare patients varies according to their
individual insurance providers [Centers for Medicare and Medicaid Services 2002].
The DRG system is used to predict costs of treatment and length of stay. It is a
tool that reflects the severity of the diagnosed ailment and difficulty of treatment and is
expected to indicate an efficient payment mechanism for health care. A basic assumption
is that a patient in the same DRG will require similar resources regardless of the type or
location of the hospital. Relative weights (RW) are assigned to each DRG to indicate the
expected resource consumption, based on historical data, required to treat a certain
ailment. A high RW indicates the case requires a high level of hospital resources, and in
most cases, a longer LOS. Base rate is the amount of money paid to the hospital per unit
of RW. The formula for computing the total hospital payment for each DRG is then:

DRG Relative Weight x Hospital Base Rate = Payment to Hospital
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(1-1)

For example, in 2005 the RW for a stroke was 1.2719 and the hospital base rate
was $4500, which results in a payment of $5,723.55 (1.2719 * $4500). Each DRG also
has an expected LOS value, which is partially used to determine the RW. In other words,
the longer the LOS, the higher the charge will generally be. As stated earlier, the
drawback of the RW and expected LOS values is that they give no indication of how they
may be impacted by certain patient characteristics or other factors. If a hospital knew
certain scenarios that dramatically affected LOS, they potentially could plan accordingly
to take advantage of these situations. For example, a patient profile prone to have a much
longer LOS than the expected value would most likely be avoided, if possible.
Moreover, if certain diagnoses consistently result in a longer than expected LOS, the
hospital may consider discontinuing these particular treatments [Centers for Medicare
and Medicaid Services 2002].

1.3.4 Approach
The model will be implemented using a variety of multivariate linear regression
analysis techniques. Since there is a considerable amount of data, software will be used
extensively to accurately and efficiently handle the storage, sorting, and analysis of the
data. All 2k possible regressions will be studied, where k is the number of possible
regressors, along with all the various interactions between them. Any categorical data
will be quantified either arbitrarily or based on some type of ranking method.
Ultimately, all statistically significant predictor variables will be determined to
develop a final regression model. With this representation, a simulation model describing
the neurological unit will be implemented. Simulation software will be used to validate
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and verify the regression model before performing full-scale testing and sensitivity
analysis with it.

1.4 Thesis Outline
This thesis consists of five chapters. Chapter 2 reviews related research in
predicting and modeling LOS that is relevant to this study. Chapter 3 explains the
methodology used in the development and testing of the regression and simulation
models. Chapter 4 presents the results of the analysis. Chapter 5 presents insight and
conclusions, based on this research, and makes recommendations for further study.
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II. Literature Review
2.1 Overview
There has been broad and extensive research performed in determining what
variables impact, and to what extent, patient LOS. Not only have various methods of
regression analysis been used in these studies, there has also been a plethora of possible
predictor variables studied. In fact, it was determined that no less than 22 different
variables influenced LOS in various studies. While objective and quantitative indicators
such as diagnosis and age were predominantly used, more subjective and qualitative
types, such as patient severity, physician characteristics, and the patient's opinion of his
or her overall health, were also commonly studied.
The objective of this review is not only to present relevant work related to this
research, but also to study and understand the methods and techniques previously used
for predicting LOS in order to possibly relate it to this analysis. While the primary focus
of this review is on work pertaining specifically with LOS, those dealing with predicting
patient costs are also examined. This was done primarily because the nature of most
hospital billing policies tends to relate health care operating costs to LOS.
The remainder of this chapter examines relevant research in analyzing and
predicting LOS relating to neurological cases (Section 2.2), followed by a review of other
research relevant to predicting LOS (Section 2.3) and an overview of some of the data
analysis methods and techniques used in these studies (Section 2.4). The chapter
concludes with an overview of software applications used in this research (Section 2.5).
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2.2 Related Work in Predicting LOS for Neurological Cases
Much of the work done in modeling LOS in neurological units has focused on
stroke cases as they are the most common neurological ailment and typically require the
most resources. Strokes are the third leading cause of death in the US among people
aged 65 and older and are also a major cause of long-term disability and rehabilitation. Its
cost to Medicare alone has been estimated to be as high as $18 billion per year [Monane
1996].
Many researchers [Bohannon et. al. 2002, Evers et. al. 2002, Hakim and Bakheit
1998 Herman et. al. 1984, Lee et al. 1997, Monane et. al. 1996, Wade and Langton 1985]
have examined patient demographics, such as age, race, gender, and marital status, in an
effort to determine if any are potential predictors of LOS in neurological cases. Several
others [Brousseau et. al. 1996, Evers et. al. 2002, Hakim and Bakheit 1998, Herman et.
al. 1984, Monane et. al. 1996, Parsons et. al. 2003, Wade and Langton 1985] have looked
at other indicators, such as insurance status, history of hospitalization, physician
experience and additional diagnoses and complications the patient may or may not have
had.
A study performed at University Hospital Maastricht in the Netherlands dealt with
731 stroke patients over the period of 1996-1998. The hospital had recently implemented
a DRG classification system similar to the US version and wanted to determine whether it
provided an accurate prediction of the variance of costs in stroke patients. The results
showed that DRGs accounted for 34% of the cost variance. Adding other variables, such
as age, gender, and additional diagnoses the patient had, increased R2 to over 61% [Evers
et. al. 2002]
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Another study [Monane et. al. 1996] looked at insurance data from 745 elderly
stroke patients and divided them into three categories: Medicare, HMOs, and other
(including Medicaid and private providers). It concluded that those belonging to HMOs
tended to have a shorter LOS, although there was evidence that many of these patients
may have been discharged to a rehabilitation unit sooner and more often than patients
belonging to other insurance providers. Two other studies analyzed the relationship
between insurance type and hospital utilization. One study [Lagoe and Lauko 1995]
found no significant relationship, while the other [Lanska 1994] found that LOS is indeed
related to insurance type, primarily those patients that belong to Medicare or a HMO.
The majority of studies have investigated the relationships between age and
hospital costs, but the results have been at best, contradictory. One study [Brousseau et.
al. 1996] reported that elderly patients require higher costs, concluding that the recovery
of older stroke patients is longer, while other studies [Lee et. al. 1997, Wade and Langton
1985] determined that younger patients utilized hospital services more. Lee explained
this by proposing that older patients receive a less aggressive approach to treatment and
tend to expire at a higher rate and earlier in the treatment phase. He also presented
evidence that some hospitals ‘pad’ their LOS statistics by discharging their terminally ill
patients to Hospices and other similar facilities.
While four studies [Burns and Douglas 1991, Hakim and Bakheit 1998, Monane
et. al. 1996, Wade and Langton 1985] examined gender relationships, only one found a
significant difference between men and women. Burns determined that men of all ages
generally have a longer LOS. Out of four studies that investigated marital status
[Christina et. al. 1991, Herman et. al. 1984, Monane et. al. 1996, Wade and Langton
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1985], two [Monane et. al. 1996, Wade and Langton 1985] concluded that being single
led to a longer hospital stay. Several authors [Burns and Douglas 1991, Christina et. al.
1991, Hakim and Bakheit 1984, Wade and Langton 1985] examined physician
characteristics and found that the more experienced doctors [Burns and Douglas 1991]
and those with a more general background [Christina et. al. 1991] tended to keep their
patients in the hospital longer. Hakim also concluded that LOS was generally shorter in
smaller hospitals within metropolitan areas and also in hospitals with a high nurse to bed
ratio.
There have also been several scales developed to better, albeit subjectively,
describe a patient’s condition or functional level. The Rankin scale, developed by a
group of neurologists, estimates a patient’s level of functioning before the stroke from 0
‘no symptoms’ to 5 ‘severe handicap’. The Canadian Neurological Scale ranges from 1.5
‘severely handicapped’ to 10 ‘no symptoms’. [Evers et. al. 2002] found that men who
score more severely on the Rankin scale induce significantly higher costs than do women
with the same scale level.
Other studies also attempted to quantify patient severity levels. In his research,
Bohannon [2002] utilized two scales: the National Institutes of Health Stroke Scale and
Barthel ADL (Activity of Daily Living) Index score. The Barthel Index consists of two
parts, pre-stroke and post-admission, and is used to gauge how well the patient
independently performs 10 activities (e.g. dressing, walking). Bohannon used these two
indexes, along with age and gender, to predict LOS, total patient charges, and discharge
destination. Analysis showed that once the post-admission Barthel score was obtained,
no other variable contributed to LOS prediction. Wade and Langton [1985] also utilized
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the Barthel Index but found very little relevance while using it.

2.3

Related Work in Predicting LOS in Non-Neurological Cases
Additional studies non-related to neurology were also analyzed. It was believed

further insight into predicting LOS could be gained from these while at the same time
avoiding ‘tunnel-vision’ from focusing too strictly on stroke cases. This section centers
more on the techniques used to gain enhanced insight into patient characteristics and
modeling of the treatment process itself.
A study [Omachonu et. al. 2004] of about 1500 Medicare patients at the
University of Miami Medical Center investigated patient characteristics and clinical
indicators for their top 5 DRGs (1, 127, 430, 462, 489) according to patient volume.
They determined that approximately 60% of LOS variance is explained by patient
characteristics and diagnosis. For DRG 1(Craniotomy, age > 17, except for trauma),
patients admitted through the emergency room tended to have a longer LOS than nonemergency patients, while married patients have a shorter LOS than unmarried patients.
For DRG 127 (Heart failure and shock), results indicate that being male, American
Indian, Cuban, Hispanic, or Caucasian would have an increased LOS of 0.72, 0.48, 0.54,
0.97, and 0.57 days, respectively. For DRG 430 (Psychoses), older, white male patients,
who at some point during their stay were transferred within the hospital, will generally
stay longer.
Another study [Parsons et. al. 2002] that tested patients with respiratory problems
developed a pre-admittance questionnaire consisting of 30 items. The answers were used
to generate values for five patient functional scales: physical, role, emotional, social, and
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cognitive. These were then used to derive a global QL (Quality of Life) score. They also
measured the patient’s 6-minute walking distance (6MWD) and administered other
physical tests that measured lung capacity and function. The results showed that for
patients experiencing fewer complications, QL and 6MWD were the strongest predictors
of LOS.
Still another study [Weingarten et. al. 1997] evaluated the relationship between
socioeconomic status and hospital resource utilization as measured by LOS for elderly
Medicare patients, age 65 and older, within Shelby County, Tennessee. Variations in
length of stay were compared across income groupings for seven different Diagnosis
Related Groups (DRGs) and relative effects are measured for socioeconomic status, age,
race, gender, discharge status, and severity of illness. Despite the lack of provider
specific and patient specific information, the analysis does suggest that, once patients
access the medical care system, socioeconomic status has a limited effect on discharge
decisions. The results also indicate that the effect of administratively necessary days on
LOS needs further policy review.
In a large university hospital in Canada, one study [Keefler et. al. 2001] was done
to examine the effects of psychosocial problems on LOS, controlling for patient
demographics and medical condition. Mean LOS for DRGs were used as a response for
severity of medical condition, and a subjective classification system called Person-inEnvironment (PIE) was used to measure psychosocial problems. Data were collected on a
sample of 160 patients: 78 in psychiatry and 82 in medical/surgical wards. In a regression
analysis, the severity of the patient's psychosocial problem was a more significant
predictor of LOS than the DRG variable. The identification of psychosocial problems and
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their severity add an important dimension to research into the effectiveness of social
workers in reducing length of stay. Health providers found patients having significantly
more problems related to their social role functioning tended to have a longer LOS than
patients with problems in the hospital environment.

2.4 Data Analysis Methods and Techniques
Since most researchers tend to work with large quantities, many choose to use a
top-to-bottom approach in analyzing their data. Once they determine exactly what
indicators they were going to study and the techniques they are to use, they analyze the
data using advanced software packages.
Some of the common software used was SAS (Statistical Analysis System)
(Ver 6.12) [Monane et. al. 1996, Omachonu et. al. 2004], of SAS Institute Inc in Cary,
NC, Statview II (Ver 1.03) [Inouye 2001], a statistical program developed by Abacus
Concept in Berkeley, CA, and SPSS (Statistical Package for the Social Sciences) (Ver
10.0) [Bohannon et. al. 2002, Brousseau et. al. 1996, McKenna et. al. 2002] software,
created by SPSS Inc. of Chicago, IL.
For simplicity, data was often grouped into bins, although the approaches vary
considerably. For example, Omachonu et. al. [2004] divided their age data into 5-year
increments while McKenna et. al. [2002] and Monane et. al. [1996] had only two age
groups (<75 and >=75). Furthermore, while most chose to make LOS continuous,
Monane divided his LOS response into 3 groups (1-5 days, 6-10 days, and >10 days).
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2.5 Overview of Software Applications
2.5.1 MATLAB (Matrix Laboratory)
MATLAB v7.1 is a high-level programming language that uses matrix-based
calculations and techniques to solve complex numerical problems. It utilizes high-quality
graphics and also provides a convenient interface to built-in state-of-the-art subroutine
libraries. It also has an interactive interface, reliable algorithmic foundation, and a fully
extensible computing environment. For more information concerning MATLAB
software, go to: http://www.mathworks.com/products/matlab/

2.5.2 ARENA
ARENA is a high-level graphical simulation language that uses hierarchical
models to simulate complex real-world systems. Results are used to better understand the
process(es) and to assist in making more informed and educated decisions relating to its
operation. For more information concerning ARENA software, go to:
http://www.arenasimulation.com/
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III. Methodology

3.1 Overview
Using neurological patient data provided by Good Samaritan Hospital (GSH), an
empirical model was developed using advanced linear regression analysis techniques.
The data includes the following information for each patient: Relative Weight (RW),
Geometric Mean Length-Of-Stay (GMLOS), and Arithmetic Mean Length-Of-Stay
(AMLOS), age, gender, and Insurance Provider (IP). Details for each of these indicators
is presented in the following section. The objective was to determine which, if any, of
these patient indicators significantly impact LOS. This model was then compared to the
output from a simulation model of the neurology unit along with general statistical
information from the raw patient data, i.e. minimum/mean/maximum LOS,
minimum/mean/maximum patient level. GSH could ultimately use this regression model
to determine a reasonably accurate expected LOS for an incoming patient based on his or
her personal data. Administrators will also be able to analyze various what-if scenarios
relating to the operation of the neurology unit which will ultimately lead to better
informed decisions concerning resources such as beds and staffing.

3.2 Background of Patient Information
The patient data was provided by GSH’s finance office and consisted of 7319 inresidence patients treated for neurological symptoms from January 2002 to June 2005.
The contents of the patient data are discussed in the following subsections.
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3.2.1 Patient Age and Gender
The patient age is given in years and has a mean of 64.35, a standard deviation of
18.03, and a minimum and maximum of 14 and 105, respectively. There are 4174
(57.03%) females and 3145 (42.97%) males.

3.2.2 Patient Diagnosis and corresponding Relative Weight, GMLOS, and AMLOS
Shortly after being admitted, each patient is given a principal diagnosis code,
based on his or her ailment(s). This code, along with other related codes, is assigned to
one and only one DRG. As stated earlier in Chapter 1, each DRG has associated RW and
LOS values. These LOS values consist of AMLOS, which is generally used as an
expected LOS based on similar historical cases requiring the same type of treatment, and
GMLOS, which is indirectly used to determine the actual payment. On average, AMLOS
is 30% higher than GMLOS. Because RW, AMLOS, and GMLOS are updated at the
beginning of every fiscal year, the model will have to be updated annually to reflect these
changes. Note that there are 323 RWs, even though there are only 115 associated DRGs
in this study. This is because RWs for most DRGs vary annually due largely to inflation
and varying treatment costs. The changes are usually minimal and therefore should have
little or no effect on the development and implementation of this model, at least for the
near future. Eventually though, these increasing RW values may result in the model
having to be adjusted to account for them.
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3.2.3 Patient Insurance Provider (IP)
This data consists of 20 categories indicating the source of payment for all
treatments. In the overwhelming majority of cases, this will be some health insurance
provider, although in a few cases, the patient pays for treatment directly (‘Self’ category).
Patient levels for each of the 20 categories vary from 19 (Other Governmental Insurance)
to 4958 (Medicare). Although the DRG system was originally created exclusively for
Medicare patients only, most hospitals, including GSH, use it for billing non-Medicare
patients as well. However, while all IPs are billed the same, the actual payment varies
for each particular IP and is subject to privacy restrictions. Therefore, this analysis can
only determine which, if any, IPs affect LOS, but cannot explain the particular reasons
for these irregularities. For instance, the fact that provider A pays a higher amount than
provider B may induce a shorter or longer stay on patient A compared to patient B,
assuming the two patients and their diagnoses are similar. Also, each individual IP may
have several different coverage policies available, each with varying payment policies.

3.2.4 Patient Admit and Discharge times
Admit and discharge times are precise to the minute and assumed, in most cases,
to be accurate and reflect the actual time the patient was present for treatment.

3.3 Exploratory Data Analysis
Since there is such a large amount of data, in some instances the model was not
developed according to each observation of patient data. Instead, mean LOS based on
certain patient characteristics was used. For example, if the regressor is RW, all the
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patients are grouped together based on his or her particular RW. The mean actual LOS
values for each RW then become the “new” observations.
This technique was primarily used in early model development, particularly to
find the relationships between the individual regressors and the response, actual LOS.
However, as the model progressed, it was determined that the model could lose some of
its information, particularly model fidelity, using this approach and eventually each of the
patients was treated as a single observation.
Again, since there is an excessive amount of patient data, efficient and effective
techniques were developed to handle it effectively. Microsoft ExcelTM software was used
to store and sort the data, while MATLABTM software was used to calculate statistical
information such as computing the means, variances, and develop all regression model
information (analysis-of-variance (ANOVA) tables, model coefficients, and residual
terms). For example, if GMLOS and patient age were the two regressors, Excel was used
to sort patients, first by GMLOS, and secondly by age. An example of this is:
⎡1.6
⎢2.1
⎢
⎢1.8
⎢
⎢1.6
⎢2.1
⎢
⎣⎢1.6

46 ⎤
75 ⎥⎥
56 ⎥
⎥
27 ⎥
44 ⎥
⎥
67 ⎦⎥

⎡1.6
⎢1.6
⎢
⎢1.6
⎢
⎢1.8
⎢2.1
⎢
⎣⎢2.1

27 ⎤
46⎥⎥
67 ⎥
⎥
56 ⎥
44⎥
⎥
75⎦⎥

where the first matrix is the original, unsorted data and the second is the resulting sorted
data. Along with the corresponding actual LOS, this sorted data would then be placed in
a text file representing an n x 3 matrix, where n is the number of observations (patients)
and the three columns are represented by x1, x2, and y, respectively. MATLAB functions
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were then written to read in these text files and calculate statistical results for each
combination of GMLOS and age. Both software packages were also used to plot the
various associated graphs.

3.4 Simple Regression Analysis
Initially, each of the six regressors (RW, GMLOS, AMLOS, age, gender, and IP)
was studied individually to determine what, if any, significance each of them had on
LOS. It was established in Chapter 1 that RW and expected LOS (GMLOS, AMLOS) all
have an intuitive relationship to LOS, i.e., generally the higher these values are, the
longer LOS and higher total costs will be, and vice versa. Because of this, these
regressors, which from this point on will be referred to as the DRG-regressors, were
plotted directly against LOS. However, using similar reasoning, there is no
corresponding relationship between the non-DRG regressors (age, gender, IP) and LOS.
Therefore, for these particular regressors, the response used was average percent
difference between expected LOS (GMLOS) and actual LOS to determine how particular
categories of each impact LOS.
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As seen in Figures 3.1, 3.2, and 3.3 below, there is indeed an increasing
relationship in LOS vs. RW, LOS vs. GMLOS, and LOS vs. AMLOS, respectively.
Mean LOS vs Relative Weight
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Figure 3.1 Mean LOS vs. Relative Weight
Mean LOS vs GMLOS
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Figure 3.2 Mean LOS vs. GMLOS
Mean LOS vs AMLOS
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Figure 3.3 Mean LOS vs. AMLOS
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Figure 3.4 below shows a logarithmic relationship between age and LOS.
Mean of % diff between GMLOS and Actual LOS v s Age (5 Year
Increments)
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Figure 3.4 Mean % Difference between GMLOS and Actual LOS vs. Age
Note that the ages were grouped into 5-year increments (11-15, 16-20,…, 101-105) and
are plotted at the midpoint of each group (13, 18,…, 103). It may be expected that a
younger, healthier person will have a shorter LOS, but the “leveling off” at higher ages is
not as easily explained. It could actually indicate elderly patients tend to expire more
frequently. This could perhaps be due to their receiving less aggressive treatment due to
frail health or a living will that has a “do not resuscitate” provision. Figure 3.5 below
shows that various IPs can also impact LOS.
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Figure 3.5 Mean % Difference between GMLOS and Actual LOS vs. IP
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Again, not knowing the detail and policies of each provider, it is not possible to explain
these trends, only that a relationship does indeed exist.
To examine the total variability of the data, a technique similar to the one used to
calculate the means was used. Figures 3.6, 3.7, and 3.8 below show how LOS variability
increases significantly as RW, GMLOS, and AMLOS increase, respectively.
LOS Variance vs Relative Weight
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Figure 3.6 LOS Variance vs. Relative Weight
LOS Variance vs GMLOS
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Figure 3.7 LOS Variance vs. GMLOS
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Figure 3.8 LOS Variance vs. AMLOS
Variability effects of the three non-DRG regressors are not nearly as significant.
As shown in Figure 3.9 below, there is clearly no relationship between age and LOS
variance.
LOS Variance vs. Age
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Figure 3.9 LOS Variance vs. Age
Using the previously defined ordering scheme for IP (Figure 3.5), Figure 3.10 reflects
that there is also no relationship between IP and LOS variance.
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LOS Variance vs. Insurance Provider
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Figure 3.10 LOS Variance vs. Insurance Provider
Gender would prove to be more difficult to study. This is because even though males
have a slightly higher variance (25.60) than females (17.79), having only two levels
makes the results inconclusive. As a result, gender was combined with age by analyzing
LOS variance at each age/gender combination. Figure 3.11 below shows no noticeable
relationship between LOS variance and age and gender.
LOS Variance vs. Age and Sex
140

LOS Variance (est.)

120
100
80
60
40
20
0
10

20

30

40

50

60

70

80

90

100

Age and Sex

Figure 3.11 LOS Variance vs. Age and Gender
In general, the non-DRG regressors have constant variability while the DRG
regressors do not. This is apparent even though there is a considerable degree of
25

“unknown” variance throughout each range due to instances of only one observation at
several values of RW, GMLOS, and AMLOS. The interactions between the DRG and
non-DRG regressors may show other effects, but at this point it is not necessary to study
and analyze them.
There are several approaches to account for this nonconstant variance. One of
them used in general practice is weighted least squares (WLS). Three various methods
using WLS are developed and implemented and will be discussed next few sections.

3.5 Least Squares Approaches
General assumptions usually made regarding the linear regression model
y = Xβ + ε are that E(ε) = 0 and Var(ε) = σ2I. This is commonly referred to as ordinary
least squares (OLS) and assumes the error term has mean vector 0, the variancecovariance matrix σ2I has uncorrelated and constant errors, and the least squares criterion
is simply the squares of the error, or residual, terms:
n

S = ∑ ( y i − yˆ i ) 2

(3-1)

i =1

However, data typically possesses nonconstant error variance, making these earlier
assumptions not only impractical, but also infeasible. The error terms still have an
expected value of 0, but now Var(ε) = V, where V is the variance-covariance matrix. If
V is strictly diagonal but with unequal diagonal elements, the observations y are

uncorrelated with unequal variances; if some of the off-diagonal elements are nonzero,
then the observations y are correlated. Since neurological diseases are generally not
communicable in anyway, it is assumed all observations are uncorrelated, and therefore V
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is strictly diagonal. These diagonal elements represent the estimated weight of each
corresponding observation. The resulting least-squares criterion now becomes:
n

S = ∑ wi ( y i − yˆ i ) 2

(3-2)

i =1

The following sections describe three various methods of developing these weights.
[Montgomery 2001].

3.5.1 Modeled Variance

In this approach, V is the variance-covariance matrix of ε, or Var(ε). However, as
mentioned previously in this chapter, there is a considerable degree of unknown variance
due to instances of only one observation at several values of RW, GMLOS, and AMLOS.
Therefore, a linear model of the variance will be developed using the estimated variances.
A potential drawback of this model is that it could generate negative values for the
expected variance unless nonnegativity constraints are induced on the fitted values.

3.5.2 Estimating Weights via Observation Frequency

The premise behind this approach is to place more emphasis on observations that
occur more frequently. For example, if a certain category of stroke occurs 50 times more
often than another, more weight is placed on the former because the variance estimate is
much more accurate and reliable compared to the latter. This method has several
advantages. It is an intuitive approach, relatively simple to implement, and can easily be
updated as more patient data becomes available. These weights are represented by W, an
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n x n diagonal matrix whose elements represent the weight estimate of each
corresponding observation.

3.5.3 Isotonic Regression

Monotonic regression is a nonparametric regression method designed for cases
where the expected value of a response variable changes isotonically (non-decreasing) or
antitonically (non-increasing) in relation to one or more regressor variables. Isotonic
N

regression satisfies the following: min

∑ C ( x ) subject to x1 ≤ x2 ≤ ··· ≤ xn , where Ci (xi)
i =1

i

i

is a convex function of xi for each i ∈ N = {1,2, ..., n}. The process effectively
“smoothes out” a response, resulting in a piecewise continuous step function which will
reduce X to k ≤ n level sets [25].
Essentially, this technique will use information from non-zero adjacent variances
to calculate a more accurate estimated variance at these points of unknown variances.
Since the variability has been shown to be non-decreasing with RW, GMLOS and
AMLOS, isotonic regression can be used to “fill in” the unknown variances for RW,
GMLOS, and AMLOS with only one observation. Figure 3.12 below gives an example
of isotonic regression by showing the previous LOS Variance vs. RW graph (Figure 3.6)
with its corresponding isotonic regression plot.
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Isotonic Regression Model of LOS Variance vs Relative Weight
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Figure 3.12 Isotonic Regression Model of LOS Variance vs. Relative Weight
The plot demonstrates how the original variance values are used to form a step function
to effectively model points where the estimated variance is zero, or unknown.

3.5.4 Derivation of WLS model parameters and ANOVA terms

Nonconstant variance dramatically alters the derivation of the model. Before
developing the updated model parameters and sum of square terms, a review of the
ordinary least squares is given. Recall that to minimize the sum of the squared error
terms,
n

S (β) = ∑ εi

2

i =1

= εT ε
= (y − Xβ) T (y − Xβ)
= y T y − 2β T X T y + β T X T Xβ

(3-3)

= −2X T y + 2X T Xβ = 0 ,

(3-4)

by satisfying:
∂S
∂β

βˆ
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which, after solving the normal equations for β, yields:
β = ( X T X ) −1 X T y

(3-5)

The formulas for SSR and SSRes are also modified to accommodate the V-1 matrix
[19]. From basic regression analysis, the total sum of squares (SST) is a measure of the
variability in y and is defined as:
n

∑(y
i =1

i

− y) 2

(3-6)

SST is actually the sum of two terms: regression sum of squares (SSR) and
residual sum of squares (SSRes). The former is generally used to indicate the proportion
(SSR/SST) of variability that can be explained by the regression model, while the latter
represents the unexplained variability. They are defined as:
n

SS R = ∑ ( yˆ i − y ) 2

(3-7)

i =1

n

SS Res = ∑ ( y i − yˆ i ) 2

(3-8)

i =1

However, in the weighted least squares case, the estimator and sum of square formulas
are modified to accommodate the V (and W) matrix:
β = ( X T V −1 X) −1 X T V −1 y

(3-9)

SS R = ( X( X T V −1 X) −1 X T V −1 y − 1y ) T V −1 ( X( X T V −1 X) −1 X T V −1 y − 1y ) (3-10)

SS Res = y T V −1 y − y T V −1 X( X T V −1 X) −1 X T V −1 y
(Full derivations of these are presented in Appendix B)
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(3-11)

3.6 Model Development
3.6.1 Regression Model Development
The main focus in the development of the model is a method for dealing with the
nonconstant (and unknown) variances. It is imperative that these variances be accurately
estimated and accounted for in the model. Weighted least squares regression is an
effective and proven method to accomplish this due to its robustness and adaptability.
Furthermore, there are several approaches to estimating the “weights”.
Ultimately, four methods were studied:
1) Ordinary Least Squares Method (OLS)
This is a general un-weighted regression method and was used as the
baseline model for comparison to the subsequent weighted methods.
2) Modeled Variance Method (WLS 1)
This is the first of the proposed weighted least squares methods. LOS
variance is modeled with the inverse fitted values of the resulting model
being used as the weight estimates.
3) Observed Frequency Method (WLS 2)
The concept behind this method is that the more common occurring
observations should be weighted more than those that occur less
frequently. This is because there is a higher confidence in the variance
estimate at these higher frequencies. Therefore, the weight estimates are
the frequencies of each corresponding observation.
4) Isotonic Regression Method (WLS 3)
Because empirical evidence suggests that LOS variance is a non-
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decreasing function of RW, GMLOS, and AMLOS, as evidenced in
Figures 3.6, 3.7, and 3.8, isotonic regression can be used to derive the
weight estimates, which are simply the inverse values of the resulting
isotonic regression of the estimated LOS variance.

3.6.2 Simulation Model Development
Using the original patient data, a simulation model of the neurology unit was
developed. This was done simply by using the admit and discharge times to develop
inter-arrival and service (treatment) times. This model will be used for comparison with
the eventual regression model(s).

3.7 Multiple Regression Analysis
Now that varying relationships between each of the regressors and LOS have been
established, multiple regressors and their interactions can be added to the model. Before
accomplishing this however, several issues must be resolved, such as data representation,
coding of the qualitative IP regressor, calculation of the variance weights, and possible
multicollinearity effects due to high correlation between some of the regressors.

3.7.1 Variable Scaling
A uniform scaling system for the regressors was implemented. This was done
because it would be very difficult to establish and analyze interactions between, for
example, RW, which ranges continuously from 0 to 20, and age, which ranges from 14 to
105 in integer increments. Scaling the data would make the magnitudes of the resulting
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estimates of the regression coefficients uniform, and therefore, easier to compare.
All regressors were scaled using unit length scaling [Montgomery 2001]:
z ij =

xij − x j
S 1jj/ 2

, i = 1, 2,…, n, j = 1, 2,…, k

(3-12)

n

where S jj = ∑ ( xij − x j ) 2

(3-13)

i =1

Note: xij is the value of regressor j at observation i, x j is the mean of regressor j, z j = 0
and

∑

n
i =1

( z ij − z j ) 2 = 1.

3.7.2 Coding of the Qualitative IP Regressor
Coding for the 20 levels of the IP regressor can either be arbitrary or logical.
However, it was shown that LOS does vary with IP (Figure 3.5). As a result, it was
believed a ranking scheme would be a slightly improved approach compared to a
completely arbitrary one. Therefore, the IPs are ranked (using unit length scaling)
ascendingly according to the average percent difference between expected LOS
(GMLOS) and actual LOS, as found in Figure 3.5 (AUTO, SELF-PAY,…, MEDICAID,
NON-CONTRACTED COMMERCIAL).

3.7.3 Data Binning
To calculate the weight estimates, the data was grouped into equally sized bins.
Rather than use a complete arbitrary number of bins, n was used, which is often the
value used in grouping data for statistical methods, such as histogram graphs. For this
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model, this value is ~85 ( 7319 ). This turns out to be a useful benchmark because
many of the predictors have approximately this many distinct values. For example, age
has 92 values (14-105). Some predictors (IP, gender) do not have this many levels, so the
number of bins for those are simply the total number of levels. RW, with 323 unique
values, was grouped into 81 bins, with each bin having approximately four values of RW.
Table 3.1 shows the number of bins for each predictor:
Table 3.1 Number of Bins for each Predictor
Unique
No of
Predictor
values
bins
RW
323
81
GMLOS
72
72
AMLOS
96
96
IP
20
20
Age
92
92
Gender
2
2
For example, male patients with GMLOS=6.7, IP=13, and Age=56, will all have the
same weight estimate, which will be calculated using that particular group of patients. If
the corresponding LOS variance estimate from this group is 25 days and the total number
of patients is 10, then the corresponding weight estimates for WLS 1 and WLS 2 will be
0.04 (1/25) and 10/7319, respectively.

3.7.4 Multicollinearity Effects
It is highly suspected that the DRG regressors, particularly GMLOS and AMLOS,
are highly linearly dependent and therefore, may be highly correlated with one another.
Since Var ( βˆ ) = σ 2 ( X T X ) (for OLS), highly linear dependent columns of X will result
in very large variances in the estimates of the model parameters.
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Table 3.2 below shows that the DRG regressors are indeed highly correlated with one
another (magnitude of coefficients > ~0.9):

RW
GMLOS
AMLOS
Age
Gender
IP

Table 3.2 Correlation Matrix ( X T X )
RW
GMLOS AMLOS
Age
Gender
1
0.906
0.904
-0.072
0.073
1
0.995
-0.018
0.035
1
-0.011
0.039
1
-0.103
1
Sym.

IP
-0.047
0.008
0.014
0.497
-0.080
1

However, these high values do not necessarily guarantee poorly estimated model
parameters when using both of the corresponding regressors in the same model. Variance
inflation factors (VIFs) are typically used to determine this. VIFs are simply the diagonal
elements of ( X T X) −1 , or ( X T V -1 X) −1 and ( X T W -1 X) −1 for WLS, accordingly.
Montgomery [18] states that if any of these exceed 5, the model parameters are poorly
estimated due to multicollinearity. As seen in Table 3.3, all three DRG regressors exceed
this limit (RW = 5.788, GMLOS = 108.455, AMLOS = 106.354).

RW
GMLOS
AMLOS
Age
Gender
IP

Table 3.3 Variance Inflation Factors ( X T X) −1
RW
GMLOS AMLOS
Age Gender
5.788
-3.795
-1.448
0.214 -0.197
108.455 -104.528 0.459
0.658
106.354 -0.630 -0.516
1.347
0.080
1.022
Sym.

IP
0.203
0.223
-0.432
-0.648
0.035
1.339

These high values indicate that any model with multiple DRG regressors will indeed have
poorly estimated model parameters. Therefore, these models will be avoided altogether.
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3.8 Model Ranking and Statistics of Performance
An approach has now been established to develop and study a regression model(s)
based on this empirical patient data. The ideal model(s) should be fairly simple, easy to
implement, and require low maintenance. While the main objectives are overall
performance and simplicity, extensive comparisons of the OLS and WLS models will
also be analyzed.
To rank each potential model, a commonly used statistic, called Mallow’s Cp, will
be used. Mallow’s Cp is a very good statistic to use when comparing models with
different values of p. This statistic is a function of the residual sum of squares (SSRes) for
the full regression model and that for the reduced model, which will be a model
containing a combination of, but not all, the regressors. The equation for Cp is:
Cp =

SS Re s ( p )
− n + 2p
σˆ 2

(3-14)

where SSRes (p)is the error sum of squares for the reduced model with p terms, σ̂ 2 is

assumed to be an unbiased estimate of MSE (Mean Square Error = SSRes/(n-p)) for the
full model and p = k + 1, where k is the number of regressors in the model. Under the
correct model, Cp is approximately equal to p and otherwise is typically greater than p,
reflecting bias in the parameter estimates in the regression equation. (A value less than p
indicates the model is over-fitted.) Thus, it is desirable to select a model in which the
value of Cp is close to p.
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IV. Results and Analysis
4.1 Overview

The results of the regression analyses and model comparisons follow. Section 4.2
outlines summary statistics for all possible regressions followed by further analysis of the
best-fit models (Section 4.3). Final model analysis is performed in Section 4.4. The
chapter concludes with a comparison of the original simulation and proposed regression
models to the original data (Section 4.5) before sensitivity analysis of the regression
coefficients is performed in Section 4.6.

4.2 Initial Regression Analysis

The initial objective was to determine the significant regressors by studying all
possible regressions. However, the standard approach to performing this was modified
somewhat. Because of the multicollinearity effects mentioned in Chapter 3, no more than
one DRG regressor will be present in any of the studied models. Moreover, because it is
assumed a DRG regressor must be present to accurately predict LOS, all models will
contain one. Because there are 3 DRG regressors (RW, GMLOS, AMLOS), 4 methods
(OLS, WLS 1, WLS 2, WLS 3), and up to K = 3 additional regressors, this consisted of
96 (3·4·2K) total regression models with the eight possible baseline regression models
shown below in Table 4.1. Model response is actual LOS.
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Table 4.1 All Possible Regressions
DRG-regressor,
DRG-regressor, IP
DRG-regressor, Age
DRG-regressor, Gender
DRG-regressor, IP, Age
DRG-regressor, IP, Gender
DRG-regressor, Age, Gender
DRG-regressor, IP, Age, Gender
With so many models to be evaluated, a systematic approach to analyzing the various
models was developed. Since Mallow’s Cp statistic is based on the number of regressors
in the model, or k, the idea was to analyze each group of models based on increasing
values of k.
Table 4.2 below shows the top 2-regressor models based on Mallow’s Cp statistic.
Table 4.2 Top 2-Regressor Models
Rank Regressors
Method Mallow's Cp
1
AMLOS, IP
WLS 2
7.7
2
AMLOS, IP
WLS 3
9.6
3
GMLOS, IP
OLS
9.7
4
AMLOS, IP
OLS
9.9
5
AMLOS, IP
WLS 2
13.5
6
GMLOS, IP
WLS 3
13.7
7
GMLOS, IP
WLS 1
16.4
8
RW IP
OLS
19.8
9
RW IP
WLS 1
25.7
10 RW IP
WLS 3
30.1
The best method overall (Mallow’s Cp = 7.7) is the AMLOS, IP model using the WLS 2
method. Another AMLOS, IP model using the WLS 3 methods is the second (Cp = 9.6)
best model. As indicated in the table, AMLOS is the most significant DRG regressor,
appearing in 4 of the top 5 models. GMLOS and RW are the second and third best DRG
regressors, respectively. IP is the most significant non-DRG regressor, while the effects
of age and gender are effectively negligible. The WLS methods, particularly WLS 2,
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typically outperform OLS, with WLS 1 and WLS 3 performing comparatively to one
another.
Results of the analysis using 3-regressor models are shown in Table 4.3 below.
Table 4.3 Top 3-regressor models
Rank
1
2
3
4
5
6
7
8
9
10

Regressors
AMLOS, IP, Age
AMLOS, IP, Age
AMLOS, IP, Age
GMLOS, IP, Age
GMLOS, IP, Age
GMLOS, IP, Age
RW, IP, Age
RW, IP, Age
RW, IP, Age
AMLOS, IP, Gender

Method
WLS 2
WLS 3
OLS
OLS
WLS 3
WLS 2
OLS
WLS 2
WLS 3
WLS 2

Mallow's
Cp
3.7
4.0
4.1
4.9
6.6
6.7
7.5
8.1
8.2
8.7

AMLOS and IP, when combined with age, continue to perform as well as they do in the
2-regressor models, with the top 3 models consisting of all three. IP continues to be the
most significant non-DRG regressor, appearing in the top 9 models, while gender appears
only once. WLS 2 remains the best method, with WLS 1 and WLS 3 performing about
the same.
Since MSres from the full regression (4-regressor) model is being used for σ̂ 2 , the
Mallow’s statistic for it will always be p, or k + 1 = 5. However, the top four 3-regressor
models are an improvement over this. This indicates that gender adds no significance to
the model, and therefore the 3-regressor models are superior to the full regression ones.
This analysis shows that the best 2 and 3 regressor models are AMLOS, IP and
AMLOS, IP, Age, respectively, using the observed frequency approach (WLS 2). Their
corresponding ANOVA tables are found in Tables 4.4 and 4.5 below.
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Table 4.4 ANOVA Table for AMLOS, IP Model
Sum of
Mean
dof
F
p-value
Source Variation
Squares
Square
Regression
186690
2 93344.8 6141.09
0
Residual
111203 7316
15.2
Total
297893 7318
Table 4.5 ANOVA Table for AMLOS, IP, Age Model
Sum of
Mean
dof
F
p-value
Squares
Square
Source Variation
Regression
182545
3 60848.5 4007.17
0
Residual
111078 7315
15.2
Total
293623 7318
Since the p-values from each of the corresponding F tests are very small, it is concluded
that LOS is related to AMLOS, IP, and/or Age. Because it is not known exactly which of
them is/are significant, further tests of model adequacy are required.

4.3 Tests on Individual Regression Coefficients

Adding a variable to any regression model increases the variance of the fitted
value ŷ so care must be used to include only those that of real value in explaining the
response. Furthermore, adding an insignificant regressor may increase the residual mean
square, possibly decreasing the model’s utility.
The hypothesis for testing the significance of the individual regression coefficient

β j is:
H0 : β j = 0
H1 : β j ≠ 0

If H 0 : β j = 0 is not rejected, this indicates regressor xj can be removed from the model.

The corresponding test statistic is:
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βˆ j

t0 =

(4-1)

σˆ 2 C jj

where Cjj is the diagonal element of ( X T X) −1 corresponding to βˆ j . Note that this will be
different from the X matrix studied earlier in Chapter 3 as X now only contains the two
or three regressors currently under study as opposed to the original six. The null
hypothesis H 0 : β j = 0 is rejected if | t 0 |> tα / 2,n − k −1 . This is actually a partial test because
coefficient βˆ j depends on all other regressor variables xi (i ≠ j) that are in the model. In
more general terms, this is a test of the contribution of xj given other variables are in the
model. As seen in Table 4.6 below, all coefficients for both models are statistically
significant (α = 0.05).
Table 4.6 Hypothesis Testing on the Individual Regression Coefficients
βˆ j
C jj
t0
t 0.025,n − k −1
Result
Model
Regressor
σ̂ 2
2 regressor

AMLOS 203.55 15.2278
IP
41.63 15.2278

1.001
1.001

52.14
10.66

1.96
1.96

Reject H0
Reject H0

3 regressor

AMLOS 203.82 15.2138
IP
30.73 15.2138
Age
10.39 15.2138

1.001
1.001
1.001

52.23
7.87
2.66

1.96
1.96
1.96

Reject H0
Reject H0
Reject H0

To determine the contribution of regressor xj, given that other regressors xi (i ≠ j) are
included in the model, the extra-sum-of-squares method is generally used. This can also
be used to investigate the contribution of a subset of regressors. For example, to
determine if some subset of r < k regressors contribute significantly, β is partitioned as:
⎡β ⎤
β =⎢ 1⎥
⎣ β2 ⎦

where β is p x 1, β 1 is (p – r) x 1, and β 2 is r x 1. The hypothesis test is then:
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H0 : β2 = 0
H1 : β 2 ≠ 0
The test statistic, which will not be derived, is:
F0 =

SS R ( β 2 | β 1 ) / r
MS Re s

(4-2)

where SS R ( β 2 | β 1 ) = SS R ( β ) − SS R ( β 1 ) , and SS R ( β ) and SS R ( β1 ) are the regression
sum of squares for β and β 1 , respectively. If F0 > Fα ,r ,n − p , H 0 is rejected, and it is
concluded at least one of the parameters of β 2 is not zero. In other words, at least one of
these regressors contributes significantly to the model. Table 4.7 below shows the results
of the extra-sum-of-squares method:
Table 4.7 Hypothesis Testing Using the Extra-Sum-of-Squares Method
Result
β2
SS R ( β )
F0
Original Model SS R ( β1 )
F0.05,1,7315
AMLOS
AMLOS, IP

41566
43297

IP
Age

43297
43415

113.67
7.76

3.84
3.84

Reject H0
Reject H0

As seen in the table, both IP and age add statistically significance to the model.
However, based on the F-statistic, IP is much more significant than age.

4.4 Model Analysis

The two proposed models, AMLOS, IP, Age and AMLOS, IP, are defined by the
following coefficients, respectively:
⎡− 1.68⎤
⎢ 0.951 ⎥
⎥
β =⎢
⎢ 0.081 ⎥
⎢
⎥
⎣ 0.006 ⎦

⎡− 1.45⎤
β = ⎢⎢ 0.956 ⎥⎥
⎢⎣ 0.092 ⎥⎦
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The mathematical formulations for each respective model are then:
y = −1.68 + 0.951x AMLOS + 0.081x IP + 0.006 x Age

(4-3)

y = −1.45 + 0.956 x AMLOS + 0.092 x IP

(4-4)

Table 4.8 shows a few of these models’ responses using observations from the original
patient data.
Table 4.8 Examples of Model Responses Using Original Patient Data
Expected Expected
IP
AMLOS Insurance Provider
Age
Value
Value
Level
(M1)
(M2)
4.6
MEDICARE
19
83
4.732
4.696
4.6
SELF PAY
2
58
3.205
3.132
13.0
ANTHEM TRADITIONAL
9
64
11.796
11.806

Observed
Value
4.263
3.630
12.915

These results show the models will generally give a more accurate expected LOS than
strictly using AMLOS. The table also shows the models produce very similar outputs.
This confirms the results of the extra-sum-of-squares method that showed age adds very
little significance to the model.

4.5 Model Comparison

Each of the two proposed regression models was compared to the original
simulation model provided to GSH. The only significant difference between the two
models is that the GSH model is based on the most recent 18 months of patient data
(January 2004 to June 2005), while the regression models consist of all 42 months of
available data. However, there was no significant change in hospital policy during this
time that would have affected the flow and type of incoming patients. Therefore, the
patient distributions, and thus the resulting models, are assumed to be effectively similar.
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All three models were simulated using ARENATM software. The statistics of
primary interest are total and mean patient level and LOS, and to a lesser extent, max
number of patients and min/max LOS. The models were simulated in replicates of 42
months, which is the total time range of the original patient data and is also long enough
to give an accurate steady-state representation of the model. Initially, 10 replicates were
run to obtain sample variances which were then used to determine the eventual number of
required replicates using the confidence interval half-width:
H = tα / 2, R −1

S

(4-5)

R

Using a predetermined error criterion (ε), the objective is then to determine the minimum
R which satisfies:
R≥(

zα / 2 S 0

ε

)2

(4-6)

For α = 0.05, ε1 = 0.15 patients for average patient level, and ε2 = 0.01 days for average
LOS, 59 replications is the required minimum that satisfies all error criterion. Table 4.9
compares statistics from the simulation and regression models to the original data.
Table 4.9 Comparison of Original Data to Simulation and Regression Models
Avg
Max
Avg
Total
Patient
Patient
LOS
% Diff
% Diff
% Diff
% Diff
Patients
Level
Level
(Days)
Original
Data
Simulation
Model
AMLOS,IP
Regression
Model
AMLOS, IP,
Age
Regression
Model

Min
LOS
(Days)

Max
LOS
(Days)

7319

----

24.98

----

42.5

----

4.443

----

0.002

94.549

7211.1

1.50%

23.838

4.79%

42.7

-0.47%

4.425

0.41%

0.095

72.103

7267.9

0.70%

25.465

-1.90%

46.6

-8.80%

4.543

-2.20%

0.421

49.289

7292.6

0.36%

25.099

-0.47%

45.5

-6.59%

4.517

-1.49%

0.562

48.925
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All three models are comparable and represent the original data well, with percent
differences for most statistics on the order of 1-3%.

4.6 Sensitivity Analysis

To test the sensitivity of the model coefficients, confidence intervals were
calculated for each of them. This was accomplished by taking a random sample (without
replacement) of half the total patients (3660 out of 7319) and in turn deriving a new
model with this “new” pool of data. Since it is assumed these coefficients are normally
distributed, the following formula was used to calculate the CIs:
Y ± tα / 2, R −1

S2
R

(4-7)

where S2 is the sample variance and R is the number of replicates. Using R = 100, and
α = 0.05, the CIs are as shown below in Table 4.10:

β0
β1
β2
β3

Table 4.10 Confidence Intervals of the Model Coefficients
AMLOS, Age, IP
AMLOS,IP
Percent
Percent
Y bar
+/Y bar
+/Diff
Diff
-1.652
0.109
6.60%
-1.434 0.076
5.30%
0.954
0.038
3.98%
0.957 0.043
4.49%
0.086
0.011 12.79%
0.094 0.009
9.57%
0.007
0.001 14.29%
------- -------------

The percentage difference values represent half of the confidence interval and indicate
how much the model coefficient is expected to vary in each direction. As expected, the
variability of the coefficient estimates is generally less for the 2-regressor model
compared to the 3-regressor values. To study the potential effects of this variability, both
lower and upper bound estimates were simulated to see if any of the major simulation
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statistics (average LOS and patient level) from Table 4.9 vary significantly. While the
overall patient levels did not change (the patient arrival distribution remains the same),
Table 4.11 below shows how average LOS varied widely from 3.976-5.187 days
compared to the narrow 4.517-4.543 day range (Table 4.9) of the original models.
Table 4.11 Comparison of Confidence Interval Bounds on Original Regression Models
AMLOS, Age, IP Model

Upper Bound
(of CI)

Original
Regression
Model

Lower Bound
(of CI)

Model
Coefficients

Average
LOS
(Days)

AMLOS,IP Model

Max
Patients

β0 = -1.761
β1 = 0.916
β2 = 0.075
β3 = 0.006
β0 = -1.680
β1 = 0.951
β2 = 0.081
β3 = 0.006
β0 = -1.543
β1 = 0.992
β2 = 0.097
β3 = 0.008

Model
Coefficients

Average
LOS
(Days)

Max
Patients

4.012

43

4.556

52

5.187

118

β0 = -1.510
3.976

45

4.534

62

5.167

> 150

β1 = 0.914
β2 = 0.085
----β0 = -1.450
β1 = 0.956
β2 = 0.092
----β0 = -1.358
β1 = 1.000
β2 = 0.103
-----

The level of patients in the upper bound once reached the maximum resource level in
ARENA. This causes the software to terminate prematurely and thus prevented the
determination of a true maximum at the upper bound. Regardless, this value is
excessively larger than the top mark (62) of the original regression models. Clearly these
results illustrate two things. Not only are the model coefficients very sensitive to change,
but also the original model coefficients developed earlier appear to be estimated
accurately, as shown by the data from the simulation runs in Table 4.9.
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V. Discussion

5.1 Conclusions

The preceding research was performed to determine what, if any, relationship
exists between general patient indicators and LOS in a neurology unit at a local hospital.
A wide variety of analysis techniques were used to study, develop, and test regression
models that will predict actual LOS more accurately than the hospital’s current system.
The process involved analyzing 6 various patient predictors, three related to the
patient’s diagnosis (RW, AMLOS, and GMLOS) which are designated as DRG
regressors. The remaining three non-DRG regressors correspond directly to the patient
(age, gender, and IP). The data consists of 7319 patients treated in-residence at Good
Samaritan Hospital in Dayton, OH, from January 2002 to June 2005.
Regression analysis involved comparing two different approaches: ordinary
(OLS) and weighted least squares (WLS). OLS was employed for its ease of
implementation and as a baseline for comparing the three subsequent models. WLS was
used as a result of extensive analysis showing increasing variability in LOS as the DRG
regressors increased. Three various WLS methods were applied.
Developing these models involved studying all possible models using all available
regressors and using Mallow’s Cp statistic to rank them. Normally, minimizing Mallow’s
Cp statistic over all possible regression models will determine the best subset model.
However, it was established early in the research process of the desire to develop a
relatively simple, maintainable model. Serious consideration was therefore given to a
minimal-regressor model with a comparatively low Mallow’s Cp value.
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This analysis involved not only determining the top performing models, but more
importantly, feasible ones. Analysis determined that all three DRG regressors are highly
linearly dependent and, consequently, highly collinear. This typically translates into the
model coefficients being poorly estimated, which was eventually demonstrated using
Variance Inflation Factors. It was ultimately concluded the final models must be limited
to having a single DRG-regressor.
With this restriction in place and also presuming this particular DRG regressor
would be the model’s most significant, choosing the most significant regressor is critical.
Throughout the entire analysis, AMLOS consistently outperformed the two remaining
DRG regressors (RW and GMLOS). This is consistent with the policies of most healthcare facilities as AMLOS is typically used to predict LOS, while RW and GMLOS
(indirectly) are used for calculating treatment costs.
For the non-DRG regressors, IP was the most significant, appearing in virtually
all of the top candidate models. In one of the final models, LOS varies over 1.75 days
when using two particular IPs. However, since there is very little information known
about each IP’s policies due to privacy issues, it can only be concluded that there is
indeed a relationship, but any possible account or explanation as to why there is cannot
be offered at this time. Any attempt to do so at this point would be pure speculation.
The two remaining non-DRG regressors, age and gender, were less significant,
although age was eventually used in one of the models. A possible reason for this is that
many DRGs are only applicable to certain age groups, which means age has already been
accounted for in many diagnoses. The insignificance of gender, on the other hand, may
easily be explained by the nervous system, unlike other systems of the human body,
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being effectively the same for each gender, and therefore will tend to have similar
diagnoses, treatments, and recovery times.
The WLS methods were very effective, with many of the associated WLS models
often outperforming OLS. The drawback to WLS is that these models generally require
more maintenance and upgrades than OLS. However, WLS provides the user with a
robust and powerful, yet simple approach to developing a regression model with
nonconstant error variance that OLS cannot offer. Furthermore, as more patient data
becomes available, the WLS models will continue to be improved considerably.
Each of the WLS approaches adds a particular element to regression analysis.
WLS 1 (modeled variance) can be used in cases where little information about the total
variance is known. If enough points are known or can be determined by some method, an
effective variance model can be developed to account for these unknown variances.
WLS 2 (probability model), on the other hand, is a very effective, albeit less theoretical,
approach to use when there is little or insufficient information known about the variance
by simply “weighting” each observation based on its frequency of occurring. WLS 3
(isotonic) is a more innovative approach to modeling error variance, where a step
function of the variance is developed by minimizing a convex function of the original
data. Its one drawback is that it must be thoroughly shown that the error variance is
either nonincreasing (antitonic) or nondecreasing (isotonic).
Because of its simplicity and ease of maintainability, the recommended model to
implement is WLS 2. As more patient data becomes available, the various weights can
easily be adjusted to continuously update and improve the model. Because WLS 1 and
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WLS 3 consist of variance models, updating them is much more involved as the entire
model has to be redeveloped to derive the new variance weights.
The final regression models are relatively simple, highly effective and have been
extensively analyzed and tested. Statistical data from their simulation runs was compared
to both that of the original patient data and a simulation model developed from the raw
patient data. Results are quite favorable, with most statistics, such as average LOS and
patient level, within 1-3% of one another. Furthermore, these models are easily
maintainable and updated as more patient and IP data becomes available.
The neurology department at Good Samaritan Hospital can now use these models
to more effectively predict LOS for an incoming patient. Inputting the patient’s AMLOS,
age, and IP into the regression model generates an expected LOS that is much more
accurate than their current guidelines for predicting LOS. Furthermore, the respective
simulation models offer a powerful tool for analyzing various what-if scenarios:
•

How does the system react to the anticipated increase in neurological patients?

•

What is the optimal number of beds that ensures minimal occurrence of patient
overflow?

•

How is average LOS and average patient level impacted by small adjustments to
the model?
This research also offers GSH a basis to possibly investigate the disparities in

LOS using two different IPs. Certain IPs may have policies that possibly induce a shorter
or longer LOS. If so, it may be possible to alter or revise these procedures.
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5.2 Future Research

Because this patient data is used primarily for billing purposes, the information it
offers is rather limited. Ideally, more descriptive information of the patient would be
desired, such as his or her past medical history and lifestyle (history of tobacco use,
recent obesity problems, etc). Furthermore, an admitted patient may have several
additional symptoms that may or may not impact LOS. However, policy states the
patient can only be charged for one, and only one, diagnosis.
Therefore, the finance office only tracks the one diagnosis code corresponding to
the billing process. Nevertheless, this will usually be the one reflecting the most
substantial and costliest treatment(s) the patient receives, and therefore will generally
impact LOS more significantly than the others. However, if the patient has several
additional diagnosis codes, it could significantly impact LOS.
Also, since there has been a significant relationship established between patient IP
and LOS, more information about each of the individuals IPs is desired. As mentioned in
Chapter 3, although each of the IPs is charged the actual amount it pays varies. If certain
details about these various payment methods were known, it may better explain the
impact IP has on LOS.
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Appendix A
List of Acronyms

ADL
AMLOS
ANOVA
CI
CMS
DRG
GMLOS
GSH
HMO
IP
LOS
MATLAB
MWD
PIE
PPS
PRESS
QL
RW
SAS
SPSS
SSR
SSRes
SST
VIF
WLS

Activity of Daily Living
Arithmetic Mean LOS
Analysis-of-Variance
Confidence Interval
Centers for Medicare and Medicaid Services
Diagnostic Related Group
Geometric Mean LOS
Good Samaritan Hospital (Dayton, OH)
Health Maintenance Organization
Insurance Provider
Length-Of-Stay
Matrix Laboratory
Minimum Walking Distance
Person-In-Environment
Prospective Payment System
Prediction Error Sum of Squares
Quality of Life
Relative Weight
Statistical Analysis System
Statistical Package for the Social Sciences
Regression Sum of Squares
Residual Sum of Squares
Total Sum of Squares
Variance Inflation Factor
Weighted Least Squares

52

Appendix B
The following are the derivations for the Regression Sum of Squares (SSR) and the
Residual Sum of Squares (SSRes) formulas, respectively:
SS R = (yˆ − 1y ) T V −1 (yˆ − 1y )
= ( Xβˆ − 1y ) T V −1 ( Xβˆ − 1y )
= ( X( X T V −1 X) −1 X T V −1 y − 1y ) T V −1 ( X( X T V −1 X) −1 X T V −1 y − 1y )
SS Re s = e T V −1e
= (y − yˆ T )V −1 (y − yˆ T )
= y T V −1 y − y T V −1 yˆ − yˆ T V −1 y + yˆ T V −1 yˆ
= y T V −1 y − y T V −1 Xβˆ − βˆ T X T V −1 y + βˆ T X T V −1 Xβˆ
= y T V −1 y − 2βˆ T X T V −1 y + βˆ T X T V −1 Xβˆ
= y T V −1 y − 2[( X T V −1 X) −1 X T V −1 y ]T X T V −1 y + [( X T V −1 X) −1 X T V −1 y ]T X T V −1 X[( X T V −1 X) −1 X T V −1 y ]
= y T V −1 y − 2y T V −1 X( X T V −1 X) −1 X T V −1 y + y T V −1 X( X T V −1 X) −1 X T V −1 X( X T V −1 X) −1 X T V −1 y
= y T V −1 y − 2y T V −1 X( X T V −1 X) −1 X T V −1 y + y T V −1 X( X T V −1 X) −1 X T V −1 y
= y T V −1 y − y T V −1 X( X T V −1 X) −1 X T V −1 y
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Appendix C
The data used in this research consists of the following Insurance Providers:
Insurance Provider
AETNA
ANTHEM MANAGED
ANTHEM TRADITIONAL
ASA
AUTO
BWC REHAB
CIGNA
CONTRACTED COMMERCIAL
HUMANA
MEDICAID
MEDICAID HMO
MEDICARE
MEDICARE HMO
MMO
NONCONTRACTED COMMERCIAL
OTHER GOVERNMENTAL
PHCS
SELF PAY
UHC MANAGED
UHC TRADITIONAL
Total Patients
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# of
Patients
64
545
51
208
63
67
38
182
36
560
63
3731
412
112
39
13
66
393
521
155
7319

Appendix D
The following is the MATLAB code used in this research:
% This function runs all possible regression models
function [x] = RunAllModels()
% Read in data matrix
[datain] = textread('AMLOS_ulsx_rawy.txt');
DataMatrix = datain;
% Set number of bins
r1 = 85;
r2 = 97;
r3 = 95;
r4 = 92;
r5 = 2;
r6 = 20;
% Run all 32 Regression Models
% AMLOS
Stats(1,:) = RunModel(1, DataMatrix, 1, r1);
% AMLOS, RW
Stats(2,:) = RunModel(2, DataMatrix, 1, r1, 2, r2);
% AMLOS, GMLOS
Stats(3,:) = RunModel(2, DataMatrix, 1, r1, 3, r3);
% AMLOS, Age
Stats(4,:) = RunModel(2, DataMatrix, 1, r1, 4, r4);
% AMLOS, Gender
Stats(5,:) = RunModel(2, DataMatrix, 1, r1, 5, r5);
% AMLOS, IP
Stats(6,:) = RunModel(2, DataMatrix, 1, r1, 6, r6);
% AMLOS, RW, GMLOS
Stats(7,:) = RunModel(3, DataMatrix, 1, r1, 2, r2, 3, r3);
% AMLOS, RW, Age
Stats(8,:) = RunModel(3, DataMatrix, 1, r1, 2, r2, 4, r4);
% AMLOS, RW, Gender
Stats(9,:) = RunModel(3, DataMatrix, 1, r1, 2, r2, 5, r5);
% AMLOS, RW, IP
Stats(10,:) = RunModel(3, DataMatrix, 1, r1, 2, r2, 6, r6);
% AMLOS, GMLOS, Age
Stats(11,:) = RunModel(3, DataMatrix, 1, r1, 3, r3, 4, r4);
% AMLOS, GMLOS, Gender
Stats(12,:) = RunModel(3, DataMatrix, 1, r1, 3, r3, 5, r5);
% AMLOS, GMLOS, IP
Stats(13,:) = RunModel(3, DataMatrix, 1, r1, 3, r3, 6, r6);
% AMLOS, Age, Gender
Stats(14,:) = RunModel(3, DataMatrix, 1, r1, 4, r4, 5, r5);
% AMLOS, Age, IP
Stats(15,:) = RunModel(3, DataMatrix, 1, r1, 4, r4, 6, r6);
% AMLOS, Gender, IP
Stats(16,:) = RunModel(3, DataMatrix, 1, r1, 5, r5, 6, r6);
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% AMLOS, RW, GMLOS, Age
Stats(17,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4);
% AMLOS, RW, GMLOS, Gender
Stats(18,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 3, r3, 5, r5);
% AMLOS, RW, GMLOS, IP
Stats(19,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 3, r3, 6, r6);
% AMLOS, RW, Age, Gender
Stats(20,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 4, r4, 5, r5);
% AMLOS, RW, Age, IP
Stats(21,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 4, r4, 6, r6);
% AMLOS, RW, Gender, IP
Stats(22,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 5, r5, 6, r6);
% AMLOS, GMLOS, Age, Gender
Stats(23,:) = RunModel(4, DataMatrix, 1, r1, 3, r3, 4, r4, 5, r5);
% AMLOS, GMLOS, Age, IP
Stats(24,:) = RunModel(4, DataMatrix, 1, r1, 3, r3, 4, r4, 6, r6);
% AMLOS, GMLOS, Gender, IP
Stats(25,:) = RunModel(4, DataMatrix, 1, r1, 3, r3, 5, r5, 6, r6);
% AMLOS, Age, Gender, IP
Stats(26,:) = RunModel(4, DataMatrix, 1, r1, 4, r4, 5, r5, 6, r6);
% AMLOS, RW, GMLOS, Age, Gender
Stats(27,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4, 5, r5);
% AMLOS, RW, GMLOS, Age, IP
Stats(28,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4, 6, r6);
% AMLOS, RW, GMLOS, Gender, IP
Stats(29,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 3, r3, 5, r5, 6, r6);
% AMLOS, RW, Age, Gender, IP
Stats(30,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 4, r4, 5, r5, 6, r6);
% AMLOS, GMLOS, Age, Gender, IP
Stats(31,:) = RunModel(5, DataMatrix, 1, r1, 3, r3, 4, r4, 5, r5, 6, r6);
% AMLOS, RW, GMLOS, Age, Gender, IP
Stats(32,:) = RunModel(6, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4, 5, r5, 6, r6);
% Set n
n = length(randMat);
% Total number of regression models
totalruns = 32;
% Generate matrix of 32 p-values corresponding to each regression model
p = [1 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 5 5 5 5 5 6];
% Set values for all 32 models
for(i = 1:totalruns)
for(j = 1:4)
% R^2 value
R2(i,j) = Stats(i,1+6*(j-1));
% Adjusted R^2 value
adjR2(i,j) = Stats(i,2+6*(j-1));
% Mean Square Error
MS(i,j) = Stats(i,4+6*(j-1));
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% Sum of Squares Total
SStot(i,j) = Stats(i,5+6*(j-1));
% PRESS Statistic
PRESS(i,j) = 1 - ((Stats(i,6+6*(j-1)))/(SStot(i,j)));
% Mallow's Cp statistic
Mallows_Cp(i,j) = ((Stats(i,3+6*(j-1)))/Stats(totalruns,4+6*(j-1))) - n +
(2*(p(i)+1));
end
end
return

% This function generates a random list of patients
function z = GenDataMatrix(In, size_of_matrix, width)
% Set a temp list from 1 to n
List = zeros(size_of_matrix,width);
% Set j to size of list
j = length(In);
% For 1 to size of list
for(i = 1:size_of_matrix)
% Find a random element and move it to the list
index = ceil((j)*rand(1));
List(i,:) = In(index,:);
% Fill in the newly opened slot
for(n = index:(length(In)-1))
In(n,:) = In(n+1,:);
end;
% Update j
j = j - 1;
end
% Return list
z = List;
return;

% This function generates the Model (Beta) coefficients, ANOVA table, and residual plots
function z = RunModel(number_of_reg, InMatrix, x1, t1, x2, t2, x3, t3, x4, t4, x5, t5 )
% Set y column
y = 7;
% Generate X and Y Matrices
X(:,1) = ones(length(InMatrix),1);
X(:,2) = InMatrix(:,x1);
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Y
= InMatrix(:,y);
if(number_of_reg >= 2)
X(:,3) = InMatrix(:,x2);
end
if(number_of_reg >= 3)
X(:,4) = InMatrix(:,x3);
end

if(number_of_reg >= 4)
X(:,5) = InMatrix(:,x4);
end
if(number_of_reg >= 5)
X(:,6) = InMatrix(:,x5);
end
if(number_of_reg >= 6)
X(:,7) = InMatrix(:,x6);
end
% Calculate Variances and Weights and set V and W Vectors
VarsAndWeights = GenerateVarsAndWeights(InMatrix, x1, t1, y);
V = VarsAndWeights(:,1);
W = VarsAndWeights(:,2);
% Derive Variance Model for WLS 2
G = GLMfit(X(:,2),V);
Var = X(:,1:2)*G;
% Set n
n = length(VarsAndWeights);
% Generate VV, WW, and VarVar (nxn) matrices from the V, W, And Var vectors
VV = zeros(n,n);
WW = zeros(n,n);
VarVar = zeros(n,n);
for(i = 1:n)
% Elements cannot be exactly zero
if(V(i,1) == 0)
VV(i,i) = 0.00000001;
else
VV(i,i) = V(i,1);
end
if(W(i,1) == 0)
WW(i,i) = 0.00000001;
else
WW(i,i) = 1/W(i,1);
end
if(Var(i,1) == 0)
VarVar(i,i) = 0.00000001;
else
VarVar(i,i) = Var(i,1);
end
end
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% Model 1: OLS Model -------------------------------------------% Calculate Beta coefficients
OLS_Model = (inv(X'*X))*X'*Y
% Calculate ANOVA Table
ANOVA(1,1:6) = ANOVAstats(OLS_Model,X,eye(n),Y,n,number_of_reg,1);
% Calculate standardized and studentized residuals
sta1 = Stand_res(OLS_Model,X,Y,ANOVA(1,4),n);
stu1 = Stud_res(OLS_Model,X,eye(n),Y,ANOVA(1,4),n,number_of_reg);
% Calculate y_hats
for(i = 1:n)
y_hat(i,1) = X(i,:)*OLS_Model;
end
% Plot residuals
figure (1)
subplot(1,2,1)
scatter(y_hat(:,1), sta1),title('M1: OLS Model Residuals'),
xlabel('y_hat'), ylabel('Standardized residual');
subplot(1,2,2)
scatter(y_hat(:,1), stu1),title('M1: OLS Model Residuals'),
xlabel('y_hat'),ylabel('Studentized residual');
% Model 2: Modeled Variance ----------------------------------% Calculate Beta coefficients
Var_Model = inv(X'*inv(VarVar)*X)*X'*inv(VarVar)*Y
% Calculate ANOVA Table
ANOVA(1,7:12) = ANOVAstats(Var_Model,X,VarVar,Y,n,number_of_reg,2);
% Calculate standardized and studentized residuals
sta2 = Stand_res(Var_Model,X,Y,ANOVA(1,10),n);
stu2 = Stud_res(Var_Model,X,VarVar,Y,ANOVA(1,10),n,number_of_reg);
% Calculate y_hats
for(i = 1:n)
y_hat(i,1) = X(i,:)*Var_Model;
end
% Plot residuals
figure (2)
subplot(1,2,1)
scatter(y_hat(:,1), sta2),title('M2: Variance Model Residuals'),
xlabel('y_hat'),ylabel('Standardized residual');
subplot(1,2,2)
scatter(y_hat(:,1), stu2),title('M2: Variance Model Residuals'),
xlabel('y_hat'),ylabel('Studentized residual');
% Model 3: Probability Model -----------------------------------
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% Calculate Beta coefficients
Prob_Model = inv(X'*inv(WW)*X)*X'*inv(WW)*Y
% Calculate ANOVA Table
ANOVA(1,13:18) = ANOVAstats(Prob_Model,X,WW,Y,n,number_of_reg,2);
% Calculate standardized and studentized residuals
sta3 = Stand_res(Prob_Model,X,Y,ANOVA(1,16),n);
stu3 = Stud_res(Prob_Model,X,WW,Y,ANOVA(1,16),n,number_of_reg);
% Calculate y_hats
for(i = 1:n)
y_hat(i,1) = X(i,:)*Prob_Model;
end
% Plot residuals
figure (3)
subplot(1,2,1)
scatter(y_hat(:,1), sta3),title('M3: Probability Model Residuals'),
xlabel('y_hat'),ylabel('Standardized residual');
subplot(1,2,2)
scatter(y_hat(:,1), stu3),title('M3: Probability Model Residuals'),
xlabel('y_hat'),ylabel('Studentized residual');
% Model 4: Isotonic Variance -----------------------------------% Calculate Isotonic vector
Isot = pavaI(V(:,1));
% Generate Isotonic matrix
Isot_matrix = zeros(n,n);
for(i = 1:n)
% Elements cannot be exactly zero
if(Isot(i) == 0)
Isot_matrix(i,i) = 0.00000001;
else
Isot_matrix(i,i) = Isot(i);
end
end
% Calculate Beta coefficients
Isot_Model = inv(X'*inv(Isot_matrix)*X)*X'*inv(Isot_matrix)*Y
% Calculate ANOVA Table
ANOVA(1,19:24) = ANOVAstats(Isot_Model,X,Isot_matrix,Y,n,number_of_reg,2);
% Calculate standardized and studentized residuals
sta4 = Stand_res(Isot_Model,X,Y,ANOVA(1,22),n);
stu4 = Stud_res(Isot_Model,X,Isot_matrix,Y,ANOVA(1,22),n,number_of_reg);
% Calculate y_hats
for(i = 1:n)
y_hat(i,1) = X(i,:)*Isot_Model;
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end
% Plot residuals
Figure (4)
subplot(1,2,1)
scatter(y_hat(:,1), sta4),title('M4: Isotonic Model Residuals'),
xlabel('y_hat'),ylabel('Standardized residual');
subplot(1,2,2)
scatter(y_hat(:,1), stu4),title('M4: Isotonic Model Residuals'),
xlabel('y_hat'),ylabel('Studentized residual');
% Return ANOVA table
z = ANOVA;
return
% This function generates the ANOVA table
function z = ANOVAstats(Model,X,V,Y,n,k,mode)
% Calculate y_hats
for(i = 1:length(Y))
Y_hat(i,1) = X(i,:)*Model;
end
% Calculate vector of y_bar’s
sum = 0;
for(i = 1:length(Y))
sum = sum + Y(i,1);
end
average = sum/length(Y);
for(i = 1:length(Y))
Y_bar(i,1) = average;
end
% Calculate SSr and SS_res
SSr
= (Y_hat-Y_bar)T*inv(V)*(Y_hat-Y_bar)
SS_res = Y'*inv(V)*Y - Y'*inv(V)*X*inv(X'*inv(V)*X)*X'*inv(V)*Y;
% Create ANOVA Table
ANOVA = zeros(3,5);
ANOVA(1,1) = SSr;
ANOVA(2,1) = SS_res;
ANOVA(3,1) = SSr + SS_res;
ANOVA(1,2) = k+1;
ANOVA(2,2) = n - (k+1);
ANOVA(3,2) = n;
ANOVA(1,3) = ANOVA(1,1)/ANOVA(1,2);
ANOVA(2,3) = ANOVA(2,1)/ANOVA(2,2);
ANOVA(1,4) = ANOVA(1,3)/ANOVA(2,3);

% Mean Square Regression
% Mean Square Residual
% F statistic

% Set output statistics
Out(1,1) = SSr/(SSr + SS_res)
Out(1,2) = 1-((n-1)/(n-k-1))*(1-Out(1,1));
Out(1,3) = ANOVA(2,1);
Out(1,4) = ANOVA(2,3);

% R^2
% adj R-squared
% Sum of Squares residual
% Mean Square
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Out(1,5) = ANOVA(3,1);
% Sum of Squares total
Out(1,6) = 1 - (PRESS(Model,X,V,Y,n,k,mode))/Out(1,5); % PRESS statistic
% Return statistics
z = Out;
return

% This function computes the standardized residuals
function z = Stand_res(Model,X,Y,MS_res,n)
for(i = 1:n)
residuals(i) = (Y(i,1) - (X(i,:)*Model))/sqrt(MS_res);
end
z = residuals;
return

% This function computes the studentized residuals
function z = Stud_res(Model,X,V,Y,MS_res,n,k)
% Calculate H and covariance matrices
H = X*inv(X'*inv(V)*X)*X'*inv(V);
cov = (eye(n)-H)*V*(eye(n)-H)T;
for(i = 1:n)
residuals(i) = (Y(i,1) - (X(i,:)*Model))/(sqrt(MS_res*cov(i,i)));
end
z = residuals;
return

% This function computes the PRESS statistic
function z = PRESS(Model,X,V,Y,n,k,mode)
% Calculate H matrix
H = X*inv(X'*inv(V)*X)*X'*inv(V);
% OLS
if(mode == 1)
newH = H;
else % WLS 2
newH = (eye(n)-H)*V*(eye(n)-H)T;
end
% Calculate PRESS statistic
PRESS_stat = 0;
for(i = 1:n)
PRESS_stat = PRESS_stat + ((Y(i,1) - (X(i,:)*Model))/(1 - newH(i,i)))^2;
end
z = PRESS_stat;
return

% This function calculates the variance and probability weight matrices
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function z = GenerateVarsAndWeights( In, x1, t1, y )
% Generate Used vector
Used = zeros(length(In),1);
% Set lower bound
low = -1;
% For each bin
for(j = 1:t1)
% Set upper bound and reset counter
upp = -1 + (2*j/t1);
cntr = 0;
% Traverse entire x1 vector
for(k = 1:length(In))
% If element falls within bounds and has not already been used
if((Used(k,1) == 0) && (In(k,x1) >= low) && (In(k,x1) <= upp))
% Increment counter
cntr = cntr + 1;
% Load y and patient values
yVector(cntr,1) = In(k,y);
patientVector(cntr,1) = k;
% Set element as being used
Used(k,1) = 1;
end
end
% For all applicable elements in this bin
for(k = 1:cntr)
% Set Variance and weight values
Out(patientVector(k,1),1) = var(yVector(1:cntr,1));
Out(patientVector(k,1),2) = cntr;
end
% Reset y and patient vectors
for(k = 1:cntr)
yVector(k,1) = 0;
patientVector(k,1) = 0;
end
end
% Return matrix
z = Out;
return
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